• One Cancer Drug To Cure All Cancers?

    March 31, 2012: by Knowledge of Health

    News reports herald a possible future cure for cancer, a cure that appears so convincing in the animal laboratory that it tempts many to think a true cancer cure may soon be at hand. But careful examination suggests what is clearly a cure in the animal lab may not be a practical cure in the oncology clinic.

    In recent times there has been a renaissance in immunotherapy for cancer. Immunotherapy aims to activate an efficient immune response against tumors or prevent cancers from occurring in the first place. Decades ago cancer researchers dismissed this approach in favor of the toxic cancer cell-killing treatments that now predominate. But now cancer researchers are reporting some breakthroughs, at least in the animal laboratory.

    Read the whole post »

  • Was Steve Jobs Really A Difficult Patient?

    October 27, 2011: by Bill Sardi

    The CNN article entitled “Steve Jobs: A Difficult Patient” provoked hundreds to comment online. Here is a sampling of some of the responses:

    • The one man who could get the best possible treatment on earth ultimately did not survive. What point does this prove?
    • What an idiot, he basically killed himself off by his own stupidity.
    • He forgot to try leaches — that is why he died.

    Mr. Jobs survived by nearly 9 years a slow-growing form of pancreatic cancer first discovered in 2003. He initially shunned surgery (a drastic operation called a Whipple procedure) which is a very trying operation for surgeon and patient. You can get a view of this complicated operation at the Mayo Clinic website here. The operation involves removal of the head of the pancreas where most tumors originate as well as removal of the gall bladder and the first part of the small intestine (duodenum) and reconnection of the digestive organs.

    Read the whole post »

  • The Most Promising Weapons Against Pancreatic Cancer Were Never Ordered For Steve Jobs

    October 10, 2011: by Bill Sardi

    The e-mails, telephone calls and personal inquiries were continuous. Since 2004 when Steve Jobs was first diagnosed with pancreatic cancer, so many people, knowing the dire prognosis of this form of cancer (97% succumb within 2 years of diagnosis), and knowing I had written a 500-page book about cancer, asked if I would write to Mr. Jobs about promising alternative therapies.

    Finally, after so many inquiries (a couple from Apple employees), I relented and wrote a letter and sent it to his office at Apple and suggested he consult with his doctors about well-referenced natural remedies, while still unproven, were the most promising.

    Doctors kept Mr. Jobs alive for 7 years with chemotherapy and finally a liver transplant. But the immune-stunting drugs employed to avoid organ rejection did him in say news reports. Mr. Jobs had some quality of life to the end, saying his goodbyes and staying on as the visible leader of Apple till his end.

    Read the whole post »

  • A For-Real Cancer Breakthrough And How You Might Be Able To Train Your Immune Cells To Do The Same Thing

    August 23, 2011: by Bill Sardi

    BLOOD CANCER CURED BY ACTIVATING IMMUNE CELLS

    The announcement was overshadowed by the gloom and doom surrounding the world economies. While the stock market was tumbling and the price of gold soaring, University of Pennsylvania researchers were reporting the first full remissions from leukemia (cancer of the blood) by activation of patients’ own white blood cells (T-cells, produced in the thymus gland).

    The announcement came on the heels of a newly reported survey showing cancer is the most feared life-threatening disease over Alzheimer’s, stroke or heart attack.

    Sluggish white blood cells (aka lymphocytes) were extracted from the patients’ own blood and genetically reprogrammed to attack roaming cancer cells. The full scientific report can be viewed here.

    A number of prior attempts to employ genetically engineered T-cells had been unsuccessful. But the recognition that a type of T-cell (CD8) has a high capability to recognize, intercept and destroy malignant cells, has been the impetus that led to this most recent discovery.

    Read the whole post »

  • Beginnings Of Cancer Traced To A Shortage Of DNA Spare Parts

    May 5, 2011: by Bill Sardi

    A remarkably simple discovery may help to explain how cancer gets started, and it may lead to an even simpler preventive remedy.

    To understand this discovery, a short course in DNA repair is required. It is well known that in early stages of cancer there is chromosomal instability caused during DNA replication. As cells divide (mitosis) and are replaced by new cells, spare parts are needed to facilitate the formation of new DNA strands. The rungs on the DNA ladder, which are called nucleotides, are lettered as A (adenine), C (cytosine), G (guanine) and T (thymine). These four nucleotides comprise the steps on the DNA ladder. A, C, G and T nucleotides are essential for DNA repair.

    Read the whole post »

  • Researchers Uncover The Cause And Cure For Breast & Prostate Cancer

    March 18, 2011: by Bill Sardi

    Knowledge of Health, Inc. (March 18, 2011) – Researchers at the Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, now explain how an imbalance in estrogen metabolism leads to improper repair of broken DNA which in turn produces gene mutations that promote breast, prostate and other cancers.

    These researchers then go on to identify two natural molecular antidotes, a sulfur compound (N-acetyl cysteine) and a molecule found in red wine (resveratrol), which can completely block the initiation of these cancers. Both of these molecules are widely available as dietary supplements. When used together these antioxidants completely abolished the formation of DNA-adducts (cancer-causing chemicals that are coupled with DNA), which is the initiating step in these cancers.

    Read the whole post »

  • Cancer: More Care, More Cost, Less Cure

    June 5, 2010: by Bill Sardi

    Health authorities don’t foresee any cancer cures on the horizon. The World Health Organization estimates annual cancer cases will rise from 12.7 million to 21 million, and cancer deaths will jump from 7.6 million to more than 13 million, by the year 2030. That’s over 35,000 people dying of cancer every day. Over those two decades, world population is projected to increase from 7.01 billion to 9.30 billion, a rise of about 30%, while cancer cases and deaths will increase by 65—70%.

    Advancing age is the harbinger of cancer

    Despite concerns over carcinogens in the environment — cancer-causing agents such as herbicides, asbestos, and hormones — cancer is an age-related disease. Cancer was not a major health problem when life expectancy was 48 years for a newborn American child in the year 1900. But the life expectancy of Americans has risen upwards to nearly 80 years today and cancer affects nearly every extended family in America.

    Read the whole post »

  • Researchers Achieve Cancer-Killing Effect With Oral-Dose Vitamin C

    January 15, 2010: by Bill Sardi

    In an overlooked study first published in 2008, for the first time, using a special liposomal form of oral-dose vitamin C, researchers in Britain demonstrated it is possible to achieve cancer-killing blood concentrations of this vitamin without undesirable side effects.

    Heretofore, National Institutes of Health Researchers claimed the maximal concentration of vitamin C that can be achieved following oral intake is not sufficient to produce a cancer-killing effect. Now British researchers demonstrate they were able to achieve blood concentrations of vitamin C that were twice what was incorrectly reported to be maximal, and in the range of what is known to be selectively toxic to tumor cells, yet not harmful to healthy cells.

    Studies with various forms of cancer show a 30%-to-50% cancer cell-killing effect at the same blood concentration of vitamin C achieved in this study. For comparison, anti-cancer drugs are approved by the FDA if they achieve 50% tumor shrinkage.

    Read the whole post »

  • Turning Off the Cancer Switch

    December 28, 2009: by Bill Sardi

    Cancer researchers now recognize that molecular signals sent to healthy cells can convert them to tumor cells and that blockage of these “cancer signals” may put an abrupt halt to tumor growth.

    Researchers now think they have found the precise molecular switch that “turns on” cancer, and this suggests an antidote to cancer may soon be at hand.

    Cancer research is on the verge of an important change in direction,” says a recent report. “The Warburg Effect returns to the cancer stage,” says another report.

    The Warburg Effect — you mean that eight-decades-old research conducted by German biochemist Otto Warburg, for which he was awarded a Nobel Prize in 1931? This means cancer researchers may have actually lost ground in their war against cancer by largely dismissing Warburg’s observations first reported in 1926.

    Read the whole post »